Central regions | Technology & innovation

Technology for third-generation flu vaccine developed in Russia

10 Sep '14
Russian scientists have created a new technology to develop a flu vaccine. The word came from Moscows NPO Microgen, a national leader in immunological solutions development and the developer of the new drug candidate.

According to Microgen, with the new technology the vaccine maker wont need adjuvants, special immunological agents that are added to a vaccine to get the immune system to produce a higher amount of antibodies. The new approach also makes sure a patient receives cross-protection even against the flu strains which the vaccine doesnt contain.

The invention, for which we have obtained a patent, will enable us to produce a flu vaccine as efficient as possible. This is a third-generation vaccine, Microgen CEO Petr Kanygin said.

The vaccine will hit the market in 2016, Microgen hopes.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations: Moscow

Latest News: Central regions
15 Oct '18 | Transport, logistics | Finance, business
11 Oct '18 | Technology & innovation | Finance, business
10 Oct '18 | Technology & innovation | Finance, business
5 Oct '18 | Technology & innovation | Finance, business
 

Feature stories

27 Aug '18
7 Jun '18
Russian scientists have come up with a new method of...
3 Apr '18
In regions most of European Russians will hardly ever...
Search (News archive - 21280)
Advertising
RB_Partners_Report
Advertising
Independent Software Developers Forum
Advertising
Marchmont News

Latest News

15 Oct '18
InSize, a Russian company, has developed and is...
11 Oct '18
Russia is stepping up support for developers of IT...
10 Oct '18
Primer Capital, a Russian venture fund, has invested...

Most read stories from last week

15 Oct '18
InSize, a Russian company, has developed and is...